Lang H, Jähne J, Flemming P, Meyer H J, Pichlmayr R
Department of Surgery, Hannover Medical School, Germany.
Eur J Surg. 1995 May;161(5):355-60.
To review our experience of different therapeutic regimens in the treatment of pseudomyxoma peritonei originating in the appendix.
Retrospective study.
University hospital, Germany.
7 Patients with histologically confirmed pseudomyxoma peritonei.
Debulking operations.
Morbidity and mortality.
Complete removal of the tumour was possible at the initial operation only in a patient with a benign tumour. Debulking operations helped the other six patients considerably, but all but one died eventually of complications of the disease (usually bowel obstruction). Two patients developed what were thought to be pulmonary metastases, and one liver metastases, but these were not confirmed histologically. The results of chemotherapy varied; only one patient was free of tumour for about four years and in another progress of the tumour was halted for about a year. Length of follow up ranged from 2-20 years.
Operation is the treatment of choice for pseudomyxoma peritonei, although complete resection is rarely feasible. Because of the low morbidity and slow growth of the tumour, reoperation is always indicated for symptoms of recurrence.
回顾我们采用不同治疗方案治疗阑尾源性腹膜假黏液瘤的经验。
回顾性研究。
德国大学医院。
7例经组织学确诊的腹膜假黏液瘤患者。
肿瘤减积手术。
发病率和死亡率。
仅1例良性肿瘤患者在初次手术时实现了肿瘤的完全切除。肿瘤减积手术对其他6例患者有很大帮助,但除1例患者外,其余最终均死于该病并发症(通常为肠梗阻)。2例患者出现疑似肺转移,1例出现肝转移,但均未得到组织学证实。化疗结果各异;仅1例患者约4年无肿瘤,另1例患者肿瘤进展停滞约1年。随访时间为2至20年。
手术是腹膜假黏液瘤的首选治疗方法,尽管完全切除很少可行。由于该肿瘤发病率低且生长缓慢,复发症状出现时总是需要再次手术。